Based on those reports, it is reasonable to suggest that suppression of HOXA4 protein might be impairing the normal development as well as proliferation of myeloid progeny and could be a potential epigenetic mechanism in BCR-ABL-independent pathway in promoting IM resistance among CML patients. Here, HOXA4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.